Gut Hormones GLP-1 and GIP Emerge as Unexpected Players in Women’s Health
A new review maps how the gut hormones behind blockbuster weight-loss drugs may also influence PCOS, endometriosis and gynaecological cancers.
Tag: semaglutide
GLP-1 Weight-Loss Drugs Outpace Europe’s Health Systems, Obesity Experts Warn
A new EASO position statement argues that Europe's health systems must be restructured around five pillars to deliver the benefits ...
Weight-Loss Drugs Outperform Older Diabetes Pills in People with HIV, Real-World Study Finds
A nine-site U.S. cohort study found that GLP-1 receptor agonists produced roughly four times more weight loss than SGLT2 inhibitors ...
Weekly Semaglutide Outperforms Older Diabetes Pills in Protecting Failing Kidneys
A large real-world study finds once-weekly semaglutide outperforms sulfonylureas, DPP4 inhibitors, and thiazolidinediones on blood sugar, weight, blood pressure, and ...
Ozempic and the Surgeon’s Knife: New Meta-Analysis Probes Wound Risks in Body Contouring Patients
The first systematic review and meta-analysis of GLP-1 receptor agonist use in body contouring surgery finds a possible wound dehiscence ...
Common Diabetes Drugs May Help Protect Hearing in Type 2 Diabetes Patients
A retrospective study from the University of Palermo links type 2 diabetes to worse hearing thresholds and finds that GLP-1 ...
Weight Loss Drugs May Trigger Hidden Malnutrition, Landmark Analysis Finds
A meta-analysis of 19 high-potency incretin trials finds that objective signs of malnutrition and lean mass loss occur far more ...
Tirzepatide Outperforms GLP-1 Drugs on Blood Sugar and Weight, Review Finds
A comparative narrative review finds tirzepatide delivers the largest HbA1c and weight reductions among incretin therapies, while semaglutide leads on ...
Semaglutide Shows Promise for Weight Loss and Cooling Inflammation in Adults Without Diabetes
A new systematic review and meta-analysis in the International Journal of Obesity examines how subcutaneous semaglutide affects weight and inflammatory ...
Weight Returns Fast After Stopping Ozempic-Style Drugs, Major Analysis Finds
A Bayesian re-analysis of six clinical trials estimates that people who stop semaglutide or tirzepatide regain roughly one kilogram per ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!